David Pyott Insider Profile
4 Followers
David Pyott, COB & CEO, Director at Allergan, holds 29.48K shares in Alnylam Pharma (Ticker: ALNY), holds 9.37K shares in Tarsus Pharmaceuticals (Ticker: TARS), holds 49.75K shares in BioMarin Pharmaceutical (Ticker: BMRN).
Profitable Transactions
6 out of 13 Profitable Transactions
Average Return
+13.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Pyott holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Pyott
David Pyott's Trading History
Allergan
Mar 19, 2015
―
Uninformative Sell
―
$0.00
Alnylam Pharma
May 22, 2026
Director
Uninformative Buy
―
$8.77M
BioMarin Pharmaceutical
May 23, 2024
Director
Uninformative Buy
―
$2.69M
Pliant Therapeutics
―
Director
―
―
Tarsus Pharmaceuticals
Apr 28, 2026
Director
Uninformative Buy
84.99K
$583.63K
Avery Dennison
Apr 24, 2020
Director
Uninformative Buy
152.09K
$2.98M
Edwards Lifesciences
May 13, 2014
Director
Uninformative Buy
―
$4.60M
List of latest transactions for each holding click on a transaction to see David Pyott's performance on stock
You May Also Like
David Pyott insider profile FAQ
What is the percentage of profitable transactions made by David Pyott?
The percentage of profitable transactions made by David Pyott is 46%.
What is the average return per transaction made by David Pyott?
The average return per transaction made by David Pyott is 13.70%.
What stocks does David Pyott hold?
David Pyott holds: AGN, ALNY, BMRN, PLRX, TARS, AVY, EW stocks.
What was David Pyott’s latest transaction?
David Pyott latest transaction was an Uninformative Buy of ―.
What was David Pyott's most profitable transaction?
David Pyott’s most profitable transaction was an Informative Buy of ALNY stock on October 14, 2016. The return on the trade was 248.20%.
What is David Pyott's role in Allergan?
David Pyott's role in Allergan is COB & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.